BACKGROUND: Steatosis is a common histological finding and a poor prognostic indicator in patients with hepatitis C virus (HCV) infection. In HCV genotype 3-infected patients, the etiology of steatosis appears to be closely correlated with unknown viral factors that increase intracellular lipid levels. We hypothesize that specific sequence polymorphisms in HCV genotype 3 core protein may be associated with hepatic intracellular lipid accumulation. METHODS: Using selected serum samples from 8 HCV genotype 3-infected patients with or without steatosis, we sequenced the HCV core gene to identify candidate polymorphisms associated with increased intracellular lipid levels. RESULTS: Two polymorphisms at positions 182 and 186 of the core protein correlated with the presence (P= .03) and absence (P= .005) of intrahepatic steatosis. Transfected liver cell lines expressing core protein with steatosis-associated polymorphisms had increased intracellular lipid levels compared with non-steatosis-associated core isolates, as measured by oil red O staining (P= .02). Site-specific mutagenesis performed at positions 182 and 186 in steatosis-associated core genes yielded proteins that had decreased intracellular lipid levels in transfected cells (P= .03). CONCLUSIONS: We have identified polymorphisms in HCV core protein genotype 3 that produce increased intracellular lipid levels and thus may play a significant role in lipid metabolism or trafficking, contributing to steatosis.
BACKGROUND:Steatosis is a common histological finding and a poor prognostic indicator in patients with hepatitis C virus (HCV) infection. In HCV genotype 3-infected patients, the etiology of steatosis appears to be closely correlated with unknown viral factors that increase intracellular lipid levels. We hypothesize that specific sequence polymorphisms in HCV genotype 3 core protein may be associated with hepatic intracellular lipid accumulation. METHODS: Using selected serum samples from 8 HCV genotype 3-infected patients with or without steatosis, we sequenced the HCV core gene to identify candidate polymorphisms associated with increased intracellular lipid levels. RESULTS: Two polymorphisms at positions 182 and 186 of the core protein correlated with the presence (P= .03) and absence (P= .005) of intrahepatic steatosis. Transfected liver cell lines expressing core protein with steatosis-associated polymorphisms had increased intracellular lipid levels compared with non-steatosis-associated core isolates, as measured by oil red O staining (P= .02). Site-specific mutagenesis performed at positions 182 and 186 in steatosis-associated core genes yielded proteins that had decreased intracellular lipid levels in transfected cells (P= .03). CONCLUSIONS: We have identified polymorphisms in HCV core protein genotype 3 that produce increased intracellular lipid levels and thus may play a significant role in lipid metabolism or trafficking, contributing to steatosis.
Authors: Paolo Fabris; Annarosa Floreani; Antonio Carlotto; Maria Teresa Giordani; Vincenzo Baldo; Clara Stecca; Lorella Marchioro; Andrea Tramarin; Tosca Bertin; Francesco Negro; Fausto de Lalla Journal: J Hepatol Date: 2004-10 Impact factor: 25.083
Authors: Pratima Sharma; Vijayan Balan; Jose Hernandez; Marianne Rosati; James Williams; Hector Rodriguez-Luna; Joan Schwartz; Edwyn Harrison; Monte Anderson; Thomas Byrne; Hugo E Vargas; David D Douglas; Jorge Rakela Journal: Dig Dis Sci Date: 2004-01 Impact factor: 3.199
Authors: Jie An; Deborah M Muoio; Masakazu Shiota; Yuka Fujimoto; Gary W Cline; Gerald I Shulman; Timothy R Koves; Robert Stevens; David Millington; Christopher B Newgard Journal: Nat Med Date: 2004-02-08 Impact factor: 53.440
Authors: Heather M Patton; Keyur Patel; Cynthia Behling; David Bylund; Lawrence M Blatt; Marc Vallée; Shanon Heaton; Andrew Conrad; Paul J Pockros; John G McHutchison Journal: J Hepatol Date: 2004-03 Impact factor: 25.083
Authors: Verena Oehler; Ana Filipe; Roland Montserret; Daniel da Costa; Gaie Brown; François Penin; John McLauchlan Journal: J Virol Date: 2012-05-16 Impact factor: 5.103
Authors: J Rowell; A J Thompson; J R Guyton; X Q Lao; J G McHutchison; J J McCarthy; K Patel Journal: Hepatol Int Date: 2011-07-07 Impact factor: 6.047